Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at ...

Three Canadian stocks to watch The TSX continues its impressive rally into October, setting fresh record highs and building ...

Researchers David Chu and Uma Singh have developed and patented a new molecule named POM-L-BHDU. This molecule has shown ...

French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...

The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a ...

After sustaining an ankle injury against Union Berlin last Sunday, Hamburger SV have confirmed that Warmed Omari will be out ...

A friendly handshake is seen as a gesture of goodwill. However, it can also be a silent carrier of harmful diseases. Germs ...

Children and adolescents are two times more likely to develop long COVID after a second infection, a study found. The study, published Sept. 30 in ...

It's important to get new sores in the genital area checked right away: it's easier to diagnose problems when they can be seen, and if your initial outbreak is treated early, you're less likely to get ...

Getting vaccinated, Chen says, is an important first step in protecting against possible Long COVID. However, the study shows ...

In a preclinical study, UC Davis Comprehensive Cancer Center scientists have developed a highly targeted gene therapy that ...